trastuzumab
Trastuzumab Intravenous: Uses, Side Effects, Interactions
Trastuzumab is a biologic antineoplastic agent that, at the time of its FDA approval in 1998, was among the first available targeted chemotherapies
เว็บไซต์ trastuzumab Trastuzumab is a biologic antineoplastic agent that, at the time of its FDA approval in 1998, was among the first available targeted chemotherapies trastuzumab Trastuzumab prolongs survival in metastatic breast cancer patients whose tumors over express HER2 It is effective when given as a single agent or in
trastuzumab Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of Trastuzumab deruxtecan is a HER2 directed antibody-drug conjugate The humanized IgG1 monoclonal antibody is linked to Trastuzumab is a monoclonal antibody targeted against the HER2 tyrosine kinase receptor The majority of patients with metastatic breast
ไม่สามารถโหลดการรับสินค้าได้ ความพร้อมใช้งาน
